Greater Occipital Nerve and Cervical Region Injection in Patients With Trigeminal Neuralgia

Not Applicable

Completed

• Conditions: Trigeminal Neuralgia
• Interventions: Drug: Lidocaine 1% Injectable Solution

• Registration Number: NCT04505280
• Lead Sponsor: Dr. Lutfi Kirdar Kartal Training and Research Hospital

Brief Summary

The aim of this study is to investigate the efficacy of greater occipital nerve block and cervical injections with lidocaine

Detailed Description

After being informed about the study and potantiel risks, all patients giving informed consent will undergo randomization in 1:1 ratio to 1% lidocaine or 0.9% saline groups

Study Timeline

• Study Start: 2020-07-01
• Study First Submitted: 2020-07-31
• Study First Submitted QC: 2020-08-05
• Study First Posted: 2020-08-10
• Primary Completion: 2022-10-01
• Study Completion: 2022-12-30
• Status Verified: 2023-02
• Last Update Submitted: 2023-02-18
• Last Update Posted: 2023-02-21

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 29

Inclusion Criteria

• Classical Trigeminal Neuralgia

Exclusion Criteria

• Secondary Trigeminal Neuralgia

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Active	Lidocaine 1% Injectable Solution	%1 lidocaine injections to greater occipital nerve and cervical region once a week for 4 weeks

Primary Outcome Measures

Name	Time	Method
Efficacy on pain severity	3 months	Efficacy on pain scores. Visual Analogue Scale (VAS). VAS is a ten-point scale where zero refers to no pain and ten refers to maximal pain
Efficacy on pain frequency	3 months	Pain frequency per day

Trial Locations

Locations (1)

Afyonkarahisar University of Health Sciences; 🇹🇷 Afyonkarahisar, Kartal/Soğanlık, Turkey